Meridian Bioscience

About:

Meridian is a fully integrated life science company that develops, manufactures, markets and distributes diagnostic test kits.

Website: http://meridianbioscience.com

Twitter/X: meridian_bio

Top Investors: National Institutes of Health

Description:

Meridian Bioscience is an integrated life science company. The Company is engaged in developing, manufacturing, selling, and distributing clinical diagnostic test kits, for certain gastrointestinal, viral, respiratory, and parasitic infectious diseases; the manufacture and distribution of bulk antigens, antibodies, polymerase chain reaction (PCR)/ quantitative polymerase chain reaction (qPCR) reagents, nucleotides, competent cells and bioresearch reagents used by researchers and other diagnostic manufacturers, and the contract development and manufacture of proteins and other biologicals under cyclic guanosine monophosphate (cGMP) conditions for use by biopharmaceutical and biotechnology companies engaged in research for new drugs and vaccines. The Company operates in three segments: U.S. Diagnostics, European Diagnostics, and Life Science.

Total Funding Amount:

$9M

Estimated Revenue Range:

$100M to $500M

Headquarters Location:

Cincinnati, Ohio, United States

Founded Date:

1977-01-01

Founders:

William J Motto

Number of Employees:

501-1000

Last Funding Date:

2022-01-31

IPO Status:

Delisted

Industries:

© 2025 bioDAO.ai